BACKGROUND: Low folate and high homocysteine (Hcy) concentrations are associated with pregnancy-related pathologies such as spina bifida. Polymorphisms in folate/Hcy metabolic enzymes may contribute to this potentially pathogenic biochemical phenotype. METHODS: The study comprised 26 Caucasian and 23 African-American premenopausal women. Subjects gave fasting blood samples for biochemical phenotyping and genotyping. Total Hcy (tHcy) and both plasma and red blood cell (RBC) folate derivatives (i.e. tetrahydrofolate [THF], 5-methylTHF [5-MTHF], and 5,10-methenylTHF [5,10-MTHF]) were measured using stable isotope dilution liquid chromatography, multiple reaction monitoring, and mass spectrometry. Eleven polymorphisms from nine folate/Hcy pathway genes were genotyped. Tests of association between genetic, lifestyle, and biochemical variables were applied. RESULTS: In African American women, tHcy concentrations were associated (p < 0.05) with total RBC folate, RBC 5-MTHF, B(12), and polymorphisms in methionine synthase (MTR) and thymidylate synthase (TYMS). In Caucasian women, tHcy concentrations were not associated with total folate levels, but were associated (p < 0.05) with RBC THF, ratios of RBC 5-MTHF:THF, and polymorphisms in 5,10-methylenetetrahydrofolate reductase (MTHFR) and MTR. In African Americans, folate derivative levels were associated with smoking, B(12), and polymorphisms in MTR, TYMS, methionine synthase reductase (MTRR), and reduced folate carrier1 (RFC1). In Caucasians, folate derivative levels were associated with vitamin use, B(12), and polymorphisms in MTHFR, TYMS, and RFC1. CONCLUSIONS: Polymorphisms in the folate/Hcy pathway are associated with tHcy and folate derivative levels. In African American and Caucasian women, different factors are associated with folate/Hcy phenotypes and may contribute to race-specific differences in the risks of a range of pregnancy-related pathologies.
BACKGROUND: Low folate and high homocysteine (Hcy) concentrations are associated with pregnancy-related pathologies such as spina bifida. Polymorphisms in folate/Hcy metabolic enzymes may contribute to this potentially pathogenic biochemical phenotype. METHODS: The study comprised 26 Caucasian and 23 African-American premenopausal women. Subjects gave fasting blood samples for biochemical phenotyping and genotyping. Total Hcy (tHcy) and both plasma and red blood cell (RBC) folate derivatives (i.e. tetrahydrofolate [THF], 5-methylTHF [5-MTHF], and 5,10-methenylTHF [5,10-MTHF]) were measured using stable isotope dilution liquid chromatography, multiple reaction monitoring, and mass spectrometry. Eleven polymorphisms from nine folate/Hcy pathway genes were genotyped. Tests of association between genetic, lifestyle, and biochemical variables were applied. RESULTS: In African American women, tHcy concentrations were associated (p < 0.05) with total RBC folate, RBC 5-MTHF, B(12), and polymorphisms in methionine synthase (MTR) and thymidylate synthase (TYMS). In Caucasian women, tHcy concentrations were not associated with total folate levels, but were associated (p < 0.05) with RBC THF, ratios of RBC 5-MTHF:THF, and polymorphisms in 5,10-methylenetetrahydrofolate reductase (MTHFR) and MTR. In African Americans, folate derivative levels were associated with smoking, B(12), and polymorphisms in MTR, TYMS, methionine synthase reductase (MTRR), and reduced folate carrier1 (RFC1). In Caucasians, folate derivative levels were associated with vitamin use, B(12), and polymorphisms in MTHFR, TYMS, and RFC1. CONCLUSIONS: Polymorphisms in the folate/Hcy pathway are associated with tHcy and folate derivative levels. In African American and Caucasian women, different factors are associated with folate/Hcy phenotypes and may contribute to race-specific differences in the risks of a range of pregnancy-related pathologies.
Authors: Christine F Skibola; Martyn T Smith; Alan Hubbard; Barry Shane; Abby C Roberts; Graham R Law; Sara Rollinson; Eve Roman; Raymond A Cartwright; Gareth J Morgan Journal: Blood Date: 2002-05-15 Impact factor: 22.113
Authors: William G Johnson; Edward S Stenroos; John R Spychala; Sansnee Chatkupt; Sue X Ming; Steven Buyske Journal: Am J Med Genet A Date: 2004-02-01 Impact factor: 2.802
Authors: J Little; M Gilmour; P A Mossey; D Fitzpatrick; A Cardy; J Clayton-Smith; A Hill; S J Duthie; A E Fryer; A M Molloy; J M Scott Journal: Cleft Palate Craniofac J Date: 2007-12-23
Authors: Anna Stanisławska-Sachadyn; Karen S Brown; Laura E Mitchell; Jayne V Woodside; Ian S Young; John M Scott; Liam Murray; Colin A Boreham; Helene McNulty; J J Strain; Alexander S Whitehead Journal: Hum Genet Date: 2008-02-05 Impact factor: 4.132
Authors: Radek Bukowski; Fergal D Malone; Flint T Porter; David A Nyberg; Christine H Comstock; Gary D V Hankins; Keith Eddleman; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Mary E D'Alton Journal: PLoS Med Date: 2009-05-12 Impact factor: 11.069
Authors: Christine M Pfeiffer; Maya R Sternberg; Zia Fazili; David A Lacher; Mindy Zhang; Clifford L Johnson; Heather C Hamner; Regan L Bailey; Jeanne I Rader; Sedigheh Yamini; R J Berry; Elizabeth A Yetley Journal: Br J Nutr Date: 2015-04-28 Impact factor: 3.718
Authors: Can Cai; Rong Xiao; Nicholas Van Halm-Lutterodt; Jie Zhen; Xiaochen Huang; Yao Xu; Shuying Chen; Linhong Yuan Journal: Nutrients Date: 2016-10-24 Impact factor: 5.717
Authors: Anna Stanisławska-Sachadyn; Joanna Borzyszkowska; Michał Krzemiński; Alicja Janowicz; Rafał Dziadziuszko; Jacek Jassem; Witold Rzyman; Janusz Limon Journal: PLoS One Date: 2019-04-02 Impact factor: 3.240